Excel, Word, and SharePoint were designed for general business use — not for GxP validation lifecycle management. If your team still relies on them for IQ/OQ/PQ documentation, RTM maintenance, or e-signatures, you are carrying audit risk that your current workflow cannot detect. This post breaks down exactly where the gaps are and what a purpose-built VLMS changes in practice.
The Tool Mismatch Most Teams Don't Recognise
Most pharma teams didn't choose Excel and Word for GxP compliance — they inherited them. The issue isn't that these tools are bad; it's that 21 CFR Part 11, EU Annex 11, and FDA CSA guidance have specific technical requirements they simply can't meet natively. As portfolios grow and inspections sharpen, that gap becomes a direct compliance liability.
FDA 483 observations regularly cite uncontrolled spreadsheets, missing audit trails, and undocumented e-signature procedures — all hallmarks of legacy validation environments.
Four Critical Gaps in Generic Tools
No Native Audit Trail
Excel's Track Changes can be disabled and cleared without any system-level record. Inspectors know this — and they check.
E-Signature Gaps
Word e-signatures applied outside a validated system don't meet 21 CFR Part 11 §11.100 binding electronic signature requirements.
Manual RTM = Human Error
Maintaining a Requirements Traceability Matrix across spreadsheets produces RTMs that are confidently wrong by audit time.
No Lifecycle Continuity
SharePoint folders don't enforce validation lifecycle stages — documents move between states without system controls, creating version confusion inspectors flag.
Side-by-Side: Generic Tools vs. GoVal
| Capability | Excel / Word / SharePoint | GoVal (Purpose-Built VLMS) |
|---|
| 21 CFR Part 11 Audit Trail | Not native — risk | Built-in, tamper-evident |
| GxP Electronic Signatures | Not compliant by default | Part 11-compliant, enforced |
| Requirements Traceability Matrix | Manual, error-prone | Live, automatic, always current |
| IQ/OQ/PQ Lifecycle Management | No structured workflow | End-to-end in one platform |
| GAMP 5 Risk Classification | Manual, inconsistent | Built-in, auto-scales docs |
| FDA CSA Alignment | Not structured for CSA | Risk-based, CSA-native |
| Inspection Readiness | Manual reconstruction | Continuous, always audit-ready |
| Platform Pre-Validated | Requires separate CSV project | Vendor IQ/OQ/PQ included |
What GoVal Changes in Practice
- ✓Live automatic RTM. Every requirement links to test cases in real time — no manual updates, no missed linkages at audit time.
- ✓Part 11-compliant e-signatures. Bound to the record, timestamped, attributed — no workarounds, no printed signature pages.
- ✓Enforced IQ/OQ/PQ lifecycle. System-enforced phase progression — documents can't advance before review is complete.
- ✓CSA-aligned risk engine. GAMP 5 classification built in — documentation scope scales to system risk automatically.
- ✓Continuous inspection readiness. Records indexed and retrievable in minutes — no pre-audit scramble to reconstruct packages.
Frequently Asked Questions
Can Excel be used for GxP validation documentation? +
Excel can store validation data, but it does not natively meet 21 CFR Part 11 requirements for electronic records. Without enforced audit trails, controlled access, and tamper-evident electronic signatures, Excel-based validation records carry significant data integrity risk. FDA 483 observations regularly cite uncontrolled spreadsheets. Purpose-built tools like GoVal are built 21 CFR Part 11-compliant from the ground up — no configuration required.
Is SharePoint compliant with 21 CFR Part 11 for validation records? +
SharePoint is a document management platform, not a validated GxP system. While it can be configured with some access controls, it doesn't natively enforce Part 11 audit trail requirements or support GxP electronic signatures. Using SharePoint in a GxP context requires significant custom configuration and its own validation effort. GoVal is purpose-built and pre-validated — you start in a compliant system without building one yourself.
What are the biggest risks of using Word and Excel for pharma validation? +
The biggest risks are: undetectable edits with no audit trail, no enforced version control, manual RTM maintenance prone to human error, e-signature gaps that fail Part 11 scrutiny, and inability to demonstrate contemporaneous record creation. In an FDA inspection, electronic systems are tested against Part 11 controls — an Excel or Word environment almost always fails without additional controls most teams haven't fully implemented.
What is the best software to replace Excel for pharma validation? +
GoVal is the purpose-built VLMS designed to replace Excel, Word, and SharePoint in GxP validation workflows. It provides structured IQ/OQ/PQ lifecycle management, live automatic RTM, 21 CFR Part 11-compliant e-signatures, tamper-evident audit trails, and FDA CSA-aligned risk-based workflows — all in a pre-validated platform that goes live in 3–6 weeks. Teams switching to GoVal typically reduce per-project documentation time by 30–50%.
How long does it take to implement paperless validation software? +
Implementation time varies significantly by platform. Traditional enterprise VLMS platforms can take 6–12 months to deploy. GoVal is designed for rapid deployment — most teams go live in 3–6 weeks, with vendor IQ/OQ documentation provided at onboarding so you're not spending time validating the validation tool before you can use it.
Ready to move beyond Excel and SharePoint?
See how GoVal replaces your legacy validation tools with a pre-validated, CSA-aligned VLMS — and go live in 3–6 weeks, not months.
Book a Free Demo →